{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:41:29Z","timestamp":1790206889958,"version":"4.1.0"},"reference-count":9,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1992,5]]},"abstract":"<jats:p>Fluticasone propionate is a new corticosteroid with low systemic bioavailability. This study reports the outcome of a double blind clinical trial comparing oral fluticasone propionate (5 mg four times daily) with placebo for the treatment of active distal ulcerative colitis. Sixty patients were treated for four weeks, with assessments at two and four weeks. One patient was withdrawn when she was found to have amoebiasis. Thus, results are presented for 29 patients who received placebo and 30 who received fluticasone propionate. The two groups were well matched for age, sex, length of history, and extent of disease. After four weeks of therapy the clinical, sigmoidoscopic, and histological responses were similar in the two groups. It is concluded that fluticasone propionate (5 mg four times daily) is not effective treatment for active distal ulcerative colitis.<\/jats:p>","DOI":"10.1136\/gut.33.5.711","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"711-714","source":"Crossref","is-referenced-by-count":40,"title":["Oral fluticasone propionate in active distal ulcerative colitis."],"prefix":"10.1136","volume":"33","author":[{"given":"P","family":"Angus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Snook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D P","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1992,5,1]]},"reference":[{"key":"ref_1","first-page":"84","article-title":"Betamethasone 17-valerate and prednisolone 21-phosphate retention enema in proctocolitis","volume":"ii:","author":"Trial, Multicentre","year":"1971","unstructured":"Multicentre Trial. Betamethasone 17-valerate and prednisolone 21-phosphate retention enema in proctocolitis. BMJ 1971; ii: 84-6.","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/gut.26.8.822","article-title":"Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis","volume":"26","author":"McIntyre, P.B.; Macrae, F.; Berghouse, L.; English, J.; LennardJones, J.E.","year":"1985","unstructured":"McIntyre PB, Macrae F, Berghouse L, English J, LennardJones JE. Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. Gut 1985; 26: 822-4.","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1155\/1988\/819089","article-title":"Clinical experience with tixocortol pivalate","volume":"2","author":"Hanauer, S.B.","year":"1988","unstructured":"Hanauer SB. Clinical experience with tixocortol pivalate. Can J Gastroenterol 1988; 2: 156-8.","journal-title":"Can J Gastroenterol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3109\/00365528708991947","article-title":"A controlled randomised trial of budesonide versus prednisolone retention enemas in active distal colitis","volume":"22","author":"true","year":"1987","unstructured":"Danielsson A, Hellers G, Lyrenas E, Lofberg R, Nilsson A, Olsson 0, et al. A controlled randomised trial of budesonide versus prednisolone retention enemas in active distal colitis. ScandJ Gastroenterol 1987; 22: 987-92.","journal-title":"ScandJ Gastroenterol"},{"key":"ref_5","first-page":"89","article-title":"Variation between observers in describing mucosal appearances in proctocolitis","volume":"i:","author":"Baron, J.H.; Connell, A.M.; Lennard-Jones, J.E.","year":"1964","unstructured":"Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ 1964; i: 89-92.","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF01296733","article-title":"Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis","volume":"27","author":"Powell-Tuck, J.; Day, D.W.; Bucknell, N.A.; Wadsworth, J.; Lennard-Jones, J.E.","year":"1982","unstructured":"Powell-Tuck J, Day DW, Bucknell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982; 27: 533-7.","journal-title":"Dig Dis Sci"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bmj.291.6506.1373","article-title":"Olsalazine for the treatment of active ulcerative colitis","volume":"291","author":"Selby, W.S.; Barr, G.D.; Ireland, A.; Mason, C.H.; Jewell, D.P.","year":"1985","unstructured":"Selby WS, Barr GD, Ireland A, Mason CH, Jewell DP. Olsalazine for the treatment of active ulcerative colitis. BMJ 1985; 291: 1373-5.","journal-title":"BMJ"},{"key":"ref_8","first-page":"123","article-title":"The efficacy of Tobramycin in the treatment of ulcerative colitis","volume":"4","author":"Burke, D.A.; Axon, A.T.R.; Clayden, S.A.; Dixon, M.F.; Johnston, D.; Lacey, R.W.","year":"1990","unstructured":"Burke DA, Axon ATR, Clayden SA, Dixon MF, Johnston D, Lacey RW. The efficacy of Tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Therap 1990; 4: 123-9.","journal-title":"Aliment Pharmacol Therap"},{"key":"ref_9","author":"Bauer, K.; Bamtje, T.A.; Sips, A.R.; Bogaerts, Y.J.M.; Gillard, C.; Kardos, P.; etal","year":"1988","unstructured":"Bauer K, Bamtje TA, Sips AR, Bogaerts YJM, Gillard C, Kardos P, etal. EurRespir] 1988; 1 (suppl 2): 201.","journal-title":"EurRespir]"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.33.5.711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T12:35:39Z","timestamp":1765629339000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.33.5.711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":9,"journal-issue":{"issue":"5","published-online":{"date-parts":[[1992,5,1]]},"published-print":{"date-parts":[[1992,5]]}},"alternative-id":["10.1136\/gut.33.5.711"],"URL":"https:\/\/doi.org\/10.1136\/gut.33.5.711","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}